1 Man2Man | Fall 2008 : Page 3
continued from page 1 characteristics of a prostate cancer and, as a result, improve diagnostic and treatment outcomes. We propose to test this premise by developing prostate maps based on advanced imaging that can be used to non-invasively predict, with millimetre accuracy, the distribution of cancer within the prostate. In essence, we want to produce a “prostate GPS” that will help guide our doctors so they can target prostate cancer with high precision when performing a biopsy or treatment for prostate cancer. Our “prostate GPS” will be generated from scans from men who will be treated with surgery. We will then test the maps against radical prostatectomy specimens using the three-dimensional tissue distribution of cancer as “the gold standard.” We anticipate our “prostate GPS” will provide new techniques to enable early detection and treatment through more accurate guidance of biopsy as well as treatments like surgery, radiation and HIFU. Our team comprises a broad cross section of scientists, statisticians, pathologists, Lexus of London Charity Golf Classic surgeons and oncologists. This multidisciplinary team will ensure our innovations are translated into clinical use as efficiently as possible. Through the grant we will be able to help train the next generation of scientists and clinicians in the use of these technical innovations to help men with prostate cancer. Glenn Bauman, MD, FRCP(C) Professor & Chair, Dept. of Oncology, University of Western Ontario Medical Director, GU Disease Site Team London Regional Cancer Program Associate Scientist Lawson Health Research Institute On June 2nd 2008 160 golfers raised $100,000 in support of prostate cancer research at London Health Sciences Centre.